Biostage, Inc. (BSTG) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Holliston, MA, United States. El CEO actual es Junli He.
BSTG tiene fecha de IPO 2013-10-21, 7 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $57.82M.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
